Drugs Made In America Acquisition (DMIIR) Total Current Liabilities (2024 - 2026)
Drugs Made In America Acquisition (DMIIR) posted quarterly Total Current Liabilities of $300864.0 for Q4 2025, up 18.09% year-over-year from $254783.0 in Q4 2024, and down 55.58% quarter-over-quarter from $677345.0 in Q3 2025.
Analysis
Drugs Made In America Acquisition (DMIIR) Total Current Liabilities (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Total Current Liabilities for 2 consecutive years, with $300864.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities rose 18.09% year-over-year to $300864.0; the TTM figure through Dec 2025 stood at $300864.0 (up 18.09% YoY), while the FY2025 annual figure was $300864.0, up 18.09% from the prior year.
- Total Current Liabilities fell to $300864.0 in Q4 2025 per DMIIR's latest filing, from $677345.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $677345.0 in Q3 2025 and bottomed at $254783.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | 76,013.00 |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | 22.16 Mn |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | 6,077.00 |
| 4 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | 5.47 Mn |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | 298,549.00 |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | 146,923.00 |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | 1.33 Mn |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | 37,265.00 |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | 2.13 Mn |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | 644,574.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 644,574.00 |
| Dec 31, 2025 | 300,864.00 |
| Sep 30, 2025 | 677,345.00 |
| Dec 31, 2024 | 254,783.00 |